Dermatologic and Ophthalmic Drugs Advisory Committee

November 4-5, 2002

Acting Industry Representative (non-voting)

R. Todd Plott, M.D.
Vice President, Clinical Research
Medicis Pharmaceutical Company
8125 N. Hayden Road
Scottsdale, Arizona 85258
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Consultants (voting)

Wilma F. Bergfeld, M.D.
Head of Clinical Research
Department of Dermatology
Cleveland Clinic Foundation
9500 Euclid Avenue Room A61
Cleveland, Ohio 44195-5001

S. James Kilpatrick, Jr., Ph.D.
Professor of Biostatistics
Medical College of Virginia
Virginia Commonwealth University
1101 East Marshall Street
Sanger Hall, Room B-1-039-A
Richmond, Virginia 23298-0032

Thomas R. Ten Have, Ph.D.
Department of Biostatistics and Clinical Epidemiology
University of Pennsylvania
School of Medicine
607 Blockley Hall
423 Guardian Drive
Philadelphia, Pennsylvania 19104-6021

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Guests Speakers (non-voting)

Albert Kligman, M.D.
University of Pennsylvania
Department of Dermatology
226 Clinical Research Building
415 Curie Boulevard
Philadelphia, Pennsylvania 19104

Harold Lehmann, M.D.
Division of Health Sciences Informatics
2024 East Monument Street 1-201
Baltimore, Maryland 21287-0007

James J. Leyden, M.D.
Professor of Dermatology
University of Pennsylvania
2nd Floor Rhoads Pavilion
3400 Spruce Street
Philadelphia, Pennsylvania 19104

Peter E. Pochi, M.D.
Emeritus Professor of Dermatology
Boston University
715 Albany Street, J-205
Boston, Massachusetts 02118

Alan R. Shalita, M.D.
Chair, Department of Dermatology
State University of New York
Downstate Medical Center
450 Clarkson Avenue
Brooklyn, New York 11203